ANA ESTHER
LÓPEZ PÉREZ
Profesora asociada
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (10)
2019
-
Fluoroscopic characterization of colonic dysmotility associated to opioid and cannabinoid agonists in conscious rats
Journal of Neurogastroenterology and Motility, Vol. 25, Núm. 2, pp. 300-315
2018
-
Painful neurotrophins and their role in visceral pain
Behavioural Pharmacology, Vol. 29, pp. 120-139
-
Preclinical evaluation of the effects on the gastrointestinal tract of the antineoplastic drug vincristine repeatedly administered to rats
Neurogastroenterology and Motility, Vol. 30, Núm. 11
2017
-
Computer vision-based diameter maps to study fluoroscopic recordings of small intestinal motility from conscious experimental animals
Neurogastroenterology and Motility, Vol. 29, Núm. 8
-
Involvement of cannabinoid signaling in vincristine-induced gastrointestinal dysmotility in the rat
Frontiers in Pharmacology, Vol. 8, Núm. FEB
-
May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat
Neurogastroenterology and Motility, Vol. 29, Núm. 3
2015
-
Effects of chronic dietary exposure to monosodium glutamate on feeding behavior, adiposity, gastrointestinal motility, and cardiovascular function in healthy adult rats
Neurogastroenterology and Motility, Vol. 27, Núm. 11, pp. 1559-1570
-
In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat
Neurogastroenterology and Motility, Vol. 27, Núm. 12, pp. 1721-1735
2014
-
X-ray analysis of the effect of the 5-HT3 receptor antagonist granisetron on gastrointestinal motility in rats repeatedly treated with the antitumoral drug cisplatin
Experimental Brain Research, Vol. 232, Núm. 8, pp. 2601-2612
2012
-
The gastrointestinal pharmacology of cannabinoids: Focus on motility
Pharmacology, Vol. 90, Núm. 1-2, pp. 1-10